Alimentary Pharmacology & Therapeutics

Review article: appropriate use of corticosteroids in Crohn's disease
pp. 313-329(17)
Authors: IRVING, P. M.; GEARRY, R. B.; SPARROW, M. P.; GIBSON, P. R.

Review article: the genetic basis of haemochromatosis
pp. 331-342(12)
Author: GRIFFITHS, W. J. H.

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori
pp. 343-357(15)
Authors: FISCHBACH, L.; EVANS, E. L.

Relationship between the Fibrotest and portal hypertension in patients with liver disease
pp. 359-368(10)
Authors: THABUT, D.; IMBERT-BISMUT, F.; CAZALS-HATEM, D.; MESSOUS, D.; MUNTENAU, M.; VALLA, D. C.; MOREAU, R.; POYNARD, T.; LEBREC, D.

Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study
pp. 369-376(8)
Authors: BRUNO, R.; SACCHI, P.; SCAGNOLARI, C.; TORRIANI, F.; MAIOCCHI, L.; PATRUNO, S.; BELLOMI, F.; FILICE, G.; ANTONELLI, G.

Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study
pp. 377-382(6)
Authors: FUNG, J.; YUEN, M.-F.; YUEN, J. C.-H.; WONG, D. K.-H.; LAI, C.-L.

Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis
pp. 383-391(9)
Authors: ENRIQUEZ, A. D.; CAMPBELL, M. S.; REDDY, K. R.

Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization
pp. 393-400(8)
Authors: SHEN, H.; AGARWAL, D.; QI, R.; CHALASANI, N.; LIANGPUNSAKUL, S.; LUMENG, L.; YOO, H.; KWO, P.

Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt
pp. 401-410(10)
Authors: EVERSON, G. T.; MARTUCCI, M. A.; SHIFFMAN, M. L.; STERLING, R. K.; MORGAN, T. R.; HOEFS, J. C.

A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
pp. 411-419(9)
Authors: LEES, C. W.; HEYS, D.; HO, G. T.; NOBLE, C. L.; SHAND, A. G.; MOWAT, C.; BOULTON-JONES, R.; WILLIAMS, A.; CHURCH, N.; SATSANGI, J.; ARNOTT, I. D. R.

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease
pp. 421-430(10)
Authors: MANSFIELD, J. C.; PARKES, M.; HAWTHORNE, A. B.; FORBES, A.; PROBERT, C. S. J.; PEROWNE, R.C.; COOPER, A.; ZELDIS, J. B.; MANNING, D. C.; HAWKEY, C. J.

Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis
pp. 431-441(11)
Authors: DUPONT, A. W.; ARGUEDAS, M. R.; WILCOX, C. M.

Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome
pp. 443-452(10)
Authors: RUBENSTEIN, J. H.; NOJKOV, B.; KORSNES, S.; ADLIS, S. A.; SHAW, M. J.; WEINMAN, B.; INADOMI, J. M.; SAAD, R.; CHEY, W. D.

Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population
pp. 453-461(9)
Authors: JUNG, H.-K.; HALDER, S.; MCNALLY, M.; LOCKE III, G. R.; SCHLECK, C. D.; ZINSMEISTER, A. R.; TALLEY, N. J.

Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
pp. 463-473(11)
Authors: KAJANDER, K.; KROGIUS-KURIKKA, L.; RINTTILÄ, T.; KARJALAINEN, H.; PALVA, A.; KORPELA, R.

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial
pp. 475-486(12)
Authors: GUYONNET, D.; CHASSANY, O.; DUCROTTE, P.; PICARD, C.; MOURET, M.; MERCIER, C.-H.; MATUCHANSKY, C.

Eosinophilic oesophagitis and coeliac disease: is there an association?
pp. 487-493(7)
Authors: QUAGLIETTA, L.; COCCORULLO, P.; MIELE, E.; PASCARELLA, F.; TRONCONE, R.; STAIANO, A.

First-line triple therapy with levofloxacin for Helicobacter pylori eradication
pp. 495-500(6)
Authors: GISBERT, J. P.; FERNÁNDEZ-BERMEJO, M.; MOLINA-INFANTE, J.; PÉREZ-GALLARDO, B.; PRIETO-BERMEJO, A.-B.; MATEOS-RODRÍGUEZ, J.-M.; ROBLEDO-ANDRÉS, P.; GONZÁLEZ-GARCÍA, G.

Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging
pp. 501-507(7)
Authors: ANAGNOSTOPOULOS, G. K.; YAO, K.; KAYE, P.; HAWKEY, C. J.; RAGUNATH, K.

Ablation and antireflux surgery for regression of Barrett's oesophagus
pp. 509-510(2)
Authors: Lenglinger, J.; Eisler, M.; Riegler, M.

Ablation and antireflux surgery for regression of Barrett's oesophagus: authors' reply
pp. 510-511(2)
Authors: Ferraris, R.; Foti, M.; Fracchia, M.